IP Library Granted Patent US 7,914,656
Granted Patent B2
US 7,914,656 · App. 11/619,796 · Granted Mar 29, 2011

Matrixes, arrays, systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,914,656
App. No.
11/619,796
Granted
Mar 29, 2011
Kind
B2
Abstract

The present invention relates to matrixes, arrays, systems and methods for analyzing biomolecules by their isoelectric point, optionally, in combination with a second dimension analysis. The assortment of matrixes, arrays and systems provided herein are useful for causing a biomolecule under the influence of an electrical field to accumulate into an buffer that comprises a pH value that is the same as the isoelectric point of the biomolecule. The methods of this invention are useful for, e.g., research and diagnostic purposes.

Claims (13)

1. A method for sorting a mixture of biomolecules comprising the steps of adding the mixture to a running buffer in a system for isoelectric focusing (IEF) in a matrix comprising at least two compartments or cells that are not adjoined, the compartments or cells containing a first IEF buffer and at least a second different IEF buffer, and a running buffer that circulates through and around the matrix delivering the mixture to the compartments, and applying a current to the running buffer until the biomolecules in the mixture are separated into the compartments.

2. The method of claim 1 for diagnosing or prediagnosing a disease state in a subject comprising the steps of:

(1) adding a sample from the subject to the running buffer in the system, generating an electrical field, and circulating the running buffer across the IEF buffer; and

(2) comparing the biomolecules in the compartments containing IEF buffers from the subject to the biomolecules from a sample from a normal subject that does not have the disease or is not predisposed to having the disease.

3. The method according to claim 1 , wherein the biomolecules from the normal subject are prepared by adding a sample from the normal subject to the running buffer, generating the electrical field and circulating the running buffer across the IEF buffer.

4. The method according to claim 1 , further comprising the step of subjecting the biomolecule to a second dimension analysis.

5. The method according to claim 4 , wherein the second dimension analysis separates the biomolecules by the mass of the biomolecule.

6. The method according to claim 5 , wherein the second dimension analysis is by polyacrylamide gel electrophoresis (PAGE).

7. The method according to claim 5 , wherein the second dimension is by Mass spectrometry, capillary electrophoresis, and liquid chromatography.

8. The method according to claim 4 , further comprising the step selected from the group consisting of:

(a) comparing the location of the biomolecule in the second dimension analysis to another biomolecule in the second dimension analysis;

(b) determining the amount of the biomolecule in the second dimension analysis.

9. The method of claim 1 for sorting a biomolecule in a sample comprisinexposing the sample to an alternating electrical field.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2013
From: PROTEIN FOREST, INC.
To: PROTEINSIMPLE
Reel/Frame 030691/0403 →
CHANGE OF NAME Recorded Jul 18, 2011
From: CELL BIOSCIENCES, INC.
To: PROTEINSIMPLE
Reel/Frame 026606/0234 →